High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Middle cerebral artery aneurysms in older women with autosomal dominant polycystic kidney disease More info: academic.oup.com/ndt/article-... @ndt-era.bsky.social, @hjanders.bsky.social

CKD progression, kidney failure, and mortality among US patients with IgA nephropathy More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort More info:https://academic.oup.com/ndt/article/40/11/2091/8122110 @ndt-era.bsky.social, @hjanders.bsky.social

A novel system to continuously estimate intradialytic blood pressure in real time More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Life support in hemodialysis emergencies—treatment standard More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Cholinergic system in patients with chronic kidney disease: cognitive and renal implications More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Late breakers that included children: ✅Setanaxib in Alport (12+) Late breakers that did NOT include children: 🚫Atacicept in IgAN 🚫CONFIDENCE 🚫PISCES: Fish oil in Dialysis 🚫LIBERATE-D 🚫balcinrenone + dapa 🚫Obintuzumab in lupus nephritis 🚫Sibeprenlimab in IgA 🚫MIL62 in membranous +more #KidneyWk

Physical activity and cardiorenal health—from associations to interventional studies More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Trends in nephrology: from “diabetic kidney disease” to “CKD with risk factor diabetes” More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Moving beyond race, geographical origin and ethnicity: genomic insights as a path forward in nephrology care More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Metagenomic profiling of gut microbiome in early chronic kidney disease More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

The genetics of steroid-resistant nephrotic syndrome in adults More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Dietary plant and animal protein intake and decline in estimated glomerular filtration rate among elderly women: a 10-year longitudinal cohort study More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Individualizing renoprotective therapy in obesity and CKD: a commentary by the Diabesity Working Group of the ERA More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Treatment of relapsing minimal change podocytopathy More info: academic.oup.com/ndt/article-... @ndt-era.bsky.social, @hjanders.bsky.social

Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

lumasiran in primary hyperoxaluria type 1 More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

EKFC or CKD-EPIASR-NB2009 formula. Which equation to use? More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Dietary vitamin E and tocopherol isoform intake and the progression of CKD More info: academic.oup.com/ndt/article-... @ndt-era.bsky.social, @hjanders.bsky.social

Acute post-streptococcal glomerulonephritis in children—treatment standard More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

SGLT2 inhibitors in CKD: are they really effective in all patients? More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Review on Renal amyloidosis More info: academic.oup.com/ndt/article-... @ndt-era.bsky.social, @hjanders.bsky.social

IgG4-RD and B cell depletion therapy More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

More on IgAN More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Now open access in @NDTsocial Anti-GBM disease - Treatment Standard 🧐 Anti-GBM and ANCA positive pts have a higher relapse risk and require maintenance immunosuppressive treatment ▶️ academic.oup.com/ndt/article/...

Kristen Tillquist, @nephrosage.bsky.social, me, and Susie Hu wrote this onconephrology topic for AJKD Core Curriculum www.sciencedirect.com/science/arti...

Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Early compensatory increase in single-kidney estimated GFR after unilateral nephrectomy is associated with a lower long-term risk of estimated GFR decline More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Treatment standard: CKD in the geriatric patient More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Which agent are you using in post kidney transplant dyslipidemia? statin, ezetimibe, PCSK9 modulators or bempedoic acid? More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Acute kidney injury, acute kidney disease and chronic kidney disease: challenges and research perspectives More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

The debate goes on: More versus less intensive blood pressure reduction and kidney function outcomes More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

A step toward personalized medicine More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social, @Richard Glassock, @Andrew Rule, @Aleksandar Denic, @delanaye.bsky.social

Key efforts to leave those 20-30 nephrons where they belong..in the kidney! Can biopsy be prevented using PLA2R in the select few? More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

Another case of assay interference and pseudo-AKI www.kireports.org/article/S246... From @kidneyint.bsky.social #NephSky

Now open access in @ndt-era.bsky.social Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: Biological challenges and clinical implications 🧐 Clinical implementation of anti-slit diaphragm antibody testing = precision dx and tx in podocytopathies ▶️ academic.oup.com/ndt/article/...

Latest episode of @freelyfiltered.bsky.social is live! This one on the two RCTs of DDAVP to prevent renal biopsy bleeding. We had special guest Vandana Niyyar join us. @medpeedskidneys.bsky.social @captainchloride.bsky.social www.nephjc.com/freelyfilter...

thanks @asnkidney.bsky.social @asnpublications.bsky.social In the Loop for highlighting our #K360 study Link journals.lww.com/kidney360/pa... #Covid #Paxlovid #Transplant

Obtaining a thorough family history is so important in kidney disease....but often more difficult than expected in clinical practice... 10 tips on how to take a proper family history in CKD patient care url: academic.oup.com/ckj/article/...

We are excited to kick off the new academic year with a #womeninnephrology event and welcome our new #nephrology fellows, Erin, Hanna, Heba, and Jessica to our WIN community @uwmedicine.bsky.social! #kidney #healthcare #research #nephsky #WomenInMedicine #AcademicLife

Antibody-mediated rejection—treatment standard More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

HDF over HD: New report from the EuDial working group More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social

More RBC casts in a case of IgAN? might mean treatable and reversible More info: academic.oup.com/ndt/article/... Image courtesy: @RenalFellowNtwk/X @ndt-era.bsky.social, @hjanders.bsky.social

CONFIDENCE trial: You know the population; now we await the results... More info: academic.oup.com/ndt/article/... @ndt-era.bsky.social, @hjanders.bsky.social